The three top trends we saw in diabetes in 2013.
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
46 readers recommended
On October 14, Cellnovo announced the start of a usability study of its mobile-enabled insulin pump in the UK. The trial will essentially study how patients like using...
50 readers recommended
On January 21, Novo Nordisk announced the launch of the NovoPen Echo in the US. This is the first and only pen device available in the US with half-unit dosing and a...
56 readers recommended
At the ADA meeting. Biodel, Latitude, and Xeris had notable announcements on their glucagon programs. First, Biodel demonstrated a prototype of its new glucagon rescue...
67 readers recommended
Newly diagnosed with type 1 diabetes? The top ten things you should know!
38 readers recommended
Last month, the Fight4MyFeet campaign launched to increase awareness of diabetic foot ulcers among people with diabetes, including a host of valuable tips on how to...
30 readers recommended
On July 31, the ADA issued a statement on the importance of accurate blood glucose meters and test strips, calling for the FDA to continually monitor product quality and...
32 readers recommended
An open letter to the FDA’s Dr. Margaret Hamburg from diaTribe .
25 readers recommended
MediSafe is a free mobile app (Android and iPhone) designed to help people integrate their medications into daily life. Patients can enter their medications into the app...
57 readers recommended
In a whirlwind of diabetes news, a glimmer of hope for reducing diabetes complications.
63 readers recommended
On January 20, Tandem announced an expanded recall on its t:slim insulin pump cartridges – the affected cartridges ( listed here ) may be at risk of insulin leaking...
31 readers recommended
The 73rd Scientific Sessions of the American Diabetes Association will be held from June 21-25 in Chicago. The five-day conference will feature hundreds of presentations...
44 readers recommended
On October 3, Orexigen announced that it submitted Contrave (naltrexone/bupropion) to the European Medicine Agency for weight loss management. Assuming a successful...
60 readers recommended
On February 19, Abbott announced a recall of FreeStyle and FreeStyle Flash blood glucose meters, which may produce low blood sugar results incorrectly when used with...
37 readers recommended
Where are we on the road to curing type 1 diabetes? Read about our eBook with the American Diabetes Association, with great inspiration from JDRF and the Helmsley...
43 readers recommended
On June 18, the American Medical Association (AMA) officially adopted policy recognizing obesity as a disease. Although the decision does not have legal force, some...
33 readers recommended
Diabetic peripheral neuropathy (DPN) is a complication that will affect about 60-70% of all people who have diabetes at some point in their lifetime. DPN causes reduced...